Growth & profitability
- Revenue has grown 10.5% per year over the past 5 years.
- Operating margin has expanded, at -63.5% in the latest year.
MLSS Financials MILESTONE SCIENTIFIC INC.
15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $9M | $6M | 71.4% | -63.5% | -$3M | — | $1M |
| 2024 | $9M | $5M | 74.6% | -78.3% | -$3M | — | $3M |
| 2023 | $10M | $7M | 69.1% | -72.3% | — | — | $3M |
| 2022 | $9M | -$9M | 55.7% | -100.2% | -$6M | — | $9M |
| 2021 | $10M | -$7M | 61.3% | -71.6% | -$4M | — | $15M |
| 2020 | $5M | -$7M | 66.6% | -137.1% | -$7M | — | $14M |
| 2019 | $8M | -$8M | 68.3% | -47.8% | -$2M | — | $2M |
| 2018 | $10M | -$7M | 46.1% | -83.1% | -$2M | — | $2M |
| 2017 | $11M | -$5M | 61.8% | -46.4% | -$1M | — | $3M |
| 2016 | — | -$6M | — | — | -$5M | — | $4M |
| 2015 | — | -$5M | — | — | — | — | $4M |
| 2014 | — | -$2M | — | — | — | — | $10M |
| 2013 | — | $1M | — | — | $1M | — | $1M |
| 2012 | — | -$870306 | — | — | -$54453 | — | $165249 |
| 2011 | — | -$1M | — | — | -$578197 | — | $96324 |
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key quarterly figures
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $2M | -$839853 | 72.3% | -38.3% | $85210 | — | $1M |
| Dec '25 | $2M | -$1M | 73.0% | -52.5% | -$229245 | — | $1M |
| Sep '25 | $2M | -$1M | 69.5% | -48.1% | — | — | $1M |
| Jun '25 | $2M | -$1M | 69.6% | -63.9% | — | — | $1M |
| Mar '25 | $2M | -$2M | 73.8% | -89.5% | -$1M | — | $2M |
| Dec '24 | $2M | -$2M | 75.0% | -101.4% | -$2M | — | $3M |
| Sep '24 | $3M | -$1M | 73.0% | -58.4% | — | — | $5M |
| Jun '24 | $2M | $223638 | 76.1% | -96.0% | — | — | $6M |
| Mar '24 | $2M | -$1M | 74.5% | -65.1% | — | — | $4M |
| Dec '23 | $2M | -$2M | 66.8% | -87.6% | — | — | $3M |
| Sep '23 | $2M | -$1M | 73.0% | -73.2% | — | — | $2M |
| Jun '23 | $3M | -$2M | 65.0% | -78.3% | — | — | $4M |
| Mar '23 | $3M | -$1M | 72.7% | -51.7% | -$2M | — | $2M |
| Dec '22 | $2M | -$2M | 48.4% | -89.9% | -$1M | — | $9M |
| Sep '22 | $2M | -$2M | 65.6% | -90.9% | — | — | $10M |
| Jun '22 | $2M | -$3M | 41.3% | -175.0% | — | — | $11M |
| Mar '22 | $3M | -$2M | 62.3% | -70.9% | -$2M | — | $13M |
| Dec '21 | $3M | -$1M | 62.5% | -54.1% | -$400342 | — | $15M |
| Sep '21 | $2M | -$2M | 64.5% | -94.0% | -$2M | — | $14M |
| Jun '21 | $2M | -$3M | 56.5% | -118.4% | -$1M | — | $16M |
Valuation over time
How the market has priced MLSS against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-earnings ratio has fallen from 7.4× (Jan '24) to 5.0× (Jun '26).
- The price-to-sales ratio has fallen from 8.9× (Mar '23) to 3.2× (Jun '26).
P/E
P/S
Frequently asked questions
Is MLSS growing its revenue and profit?
Over the past 5 years, MILESTONE SCIENTIFIC INC.'s revenue has grown 10.5% per year. These are computed facts, not advice.
How much debt does MLSS have?
As of FY2025, MILESTONE SCIENTIFIC INC. reported — of total debt against $1M of cash.
What is MLSS's profit margin?
In FY2025, gross margin was 71.4%, operating margin -63.5%, and net margin 63.8%.
What is MLSS's P/E ratio?
As of Jun '26, MILESTONE SCIENTIFIC INC. traded at a price-to-earnings ratio of about 5.0× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.